Does ROSUVASTATIN Cause Therapy cessation? 142 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Therapy cessation have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.4% of all adverse event reports for ROSUVASTATIN.
142
Reports of Therapy cessation with ROSUVASTATIN
0.4%
of all ROSUVASTATIN reports
2
Deaths
28
Hospitalizations
How Dangerous Is Therapy cessation From ROSUVASTATIN?
Of the 142 reports, 2 (1.4%) resulted in death, 28 (19.7%) required hospitalization, and 5 (3.5%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 142 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ROSUVASTATIN Alternatives Have Lower Therapy cessation Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN